Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2003) 5 P215

BES2003 Poster Presentations Steroids (39 abstracts)

11Beta-hydroxysteroid dehydrogenase in human fibroblasts: Expression and regulation depends on tissue of origin

J Moore 1 , A Filer 2 , CD Buckley 2 , PM Stewart 1 , M Hewison 1 & MS Cooper 1


1Department of Endocrinology, University of Birmingham, Birmingham, UK; 2Department of Rheumatology, University of Birmingham, Birmingham, UK.


Fibroblasts are important regulators of local inflammatory responses. These responses are further regulated by tissue glucocorticoid levels. Other stromal lineage cells, adipocytes and osteoblasts, express 11beta-hydroxysteroid dehydrogenases (11b-HSDs) which interconvert inactive cortisone and active cortisol. These enzymes are important regulators of local glucocorticoid levels and their expression is regulated by proinflammatory cytokines. We therefore examined expression of 11b-HSDs and their regulation by TNFalpha in primary fibroblasts cultured from a range of human tissues (tonsil, lymph node, spleen, lung, skin, synovium (normal, rheumatoid and osteoarthritic)).
Fibroblasts were generated by outgrowth from donated tissues. Enzyme expression was examined by quantitative RT-PCR with primers for 11b-HSD1 and 2 and GR expression by semi-quantitative RT-PCR. 11b-HSD activity was determined by incubation with 100nM cortisol/cortisone (with tritiated tracer) with conversion quantified by TLC. The effect of 10ng/ml TNFalpha on enzyme expression was determined after 72hr treatments.
11b-HSD1 mRNA was expressed at relatively high levels in fibroblasts from all tissues (n=10). 11b-HSD2 expression was 25 fold less than for 11b-HSD1. Reductase activity (cortisone-cortisol conversion) was present in fibroblasts from all tissues (1.2+/-0.2pmol/mg/hr; mean+/-SE). Dehydrogenase activity was less prominent (0.6+/-0.3pmol/mg/hr).
TNFalpha treatment resulted in a 23 fold (14-37+/-SE; p<0.001) increase in 11b-HSD1 mRNA expression whilst 11b-HSD2 expression was further reduced 4 fold (2-8+/-SE; p<0.05). 11b-HSD1 reductase activity increased substantially (3.8+/-0.8 fold; p<0.05) but dehydrogenase activity was unchanged (1.1+/-0.3 fold) suggesting an independent effect on enzyme directionality. GR expression was unchanged. Interestingly dermal fibroblasts, despite increased 11b-HSD1 mRNA levels with TNFalpha, displayed reduced 11b-HSD1 reductase activity (1.0+/-0.2 vs 0.6+/-0.2pmol/mg/hr; n=4, p<0.05).
Fibroblasts from a range of human tissues express 11b-HSD1 and this activity is predominantly reductase. TNFalpha potently induces this activity in fibroblasts from most, but not all, tissues. Tissue dependent regulation of fibroblastic 11b-HSD1 activity may be a factor in determining tissue specific responses to inflammation.

Volume 5

22nd Joint Meeting of the British Endocrine Societies

British Endocrine Societies 

Browse other volumes

Article tools

My recent searches

No recent searches.